Press Releases
Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody...
Abpro, a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases, announced the formation of...
Press Releases
FDA approves GSKs Advil Dual Action with Acetaminophen for...
GlaxoSmithKline announced that the U.S. FDA has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief. The exclusive formula is...
Drug Research
Catalent Announces Supplying Blueprint Medicines Precision Therapy AYVAKIT
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health products, welcomes...
Clinical Trials
Rare Disease Patient Platform Raremark Partners With TriNetX
TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), announced that Raremark, a patient-data...
Press Releases
Signant Health invests for growth with the opening of...
Signant Health, an industry-leading clinical research technology and solutions company, is proud to announce that it has officially opened a new, leading edge office facility...
Press Releases
Sun Pharma Launches RIOMET ER Oral Suspension in the...
Sun Pharmaceutical Industries Ltd. announced that one of its whollyowned subsidiaries has launched Riomet ERâ„¢ in the U.S. as an adjunct to diet and exercise...
Press Releases
Dulaglutide Receives FDA Approval for Reducing MACE in Type...
The U.S. FDA has approved Trulicity® (dulaglutide) for the reduction of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who have established...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.